TITLE

Ursodeoxycholic Acid and Long-Term Survival in Primary Biliary Cirrhosis

AUTHOR(S)
Levy, Cynthia
PUB. DATE
February 2004
SOURCE
American Journal of Gastroenterology;Feb2004, Vol. 99 Issue 2, p269
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Comments on issues about the potential therapeutic value of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC). Use of orthotopic liver transplantation (OLT) to cure PBC; Investigation on the extent of benefit of UDCA therapy with or without OLT; Significance of the study on the provision of insights regarding the effect of UDCA therapy in patients with PBC.
ACCESSION #
14816716

 

Related Articles

  • Prolonged Follow-Up of Patients in the U.S. Multicenter Trial of Ursodeoxycholic Acid for Primary Biliary Cirrhosis. Combes, Burton; Luketic, Velimir A.; Peters, Marion G.; Zetterman, Rowen K.; Garcia-Tsao, Guadalupe; Munoz, Santiago J.; Lin, Danyu; Flye, Nancy; Carithers, Robert L. // American Journal of Gastroenterology;Feb2004, Vol. 99 Issue 2, p264 

    OBJECTIVE: Randomized, double-blind, placebo-controlled trials of ursodeoxycholic acid (UDCA) in patients with primary biliary cirrhosis (PBC) have not demonstrated improvement in survival during the placebo-controlled phases of these trials. Analyses purporting to demonstrate a survival...

  • LATE GRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION FOR PRIMARY BILIARY CIRRHOSIS: DISEASE RECURRENCE VERSUS CHRONIC GRAFT REJECTION. Lerut, Jan P.; Zimmermann, Arthur; Gertsch, Philippe // American Journal of Gastroenterology;Oct1994, Vol. 89 Issue 10, p1896 

    Possible recurrence of primary biliary cirrhosis (PBC) in the transplanted liver has been reported. We discuss a case of presumed PBC recurrence after liver transplantation. However, the patient's full documented 9-yr follow-up after liver transplantation confirmed the diagnosis of chronic liver...

  • Advances in treatment of primary biliary cirrhosis. QIN Hua; BAI Shishan // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;sep2013, Vol. 29 Issue 9, following p719 

    Primary biliary cirrhosis (PBC) is a chronic progressive intrahepatic cholestatic disease of unknown cause, and its incidence is increasing year by year. The main therapies for PBC include ursodeoxycholic acid for cholestasis, glucocorticoid or immunosuppressant for abnormal immune response, and...

  • Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008. Kuiper, Edith M. M.; Hansen, Bettina E.; Metselaar, Herold J.; de Man, Robert A.; Haagsma, Els B.; van Hoek, Bart; van Buuren, Henk R. // BMC Gastroenterology;2010, Vol. 10, p144 

    Background: A decrease in the need for liver transplantations (LTX) in Primary Biliary Cirrhosis (PBC), possibly related to treatment with ursodeoxycholic acid (UDCA), has been reported in the USA and UK. The aim of this study was to assess LTX requirements in PBC over the past 20 years in the...

  • Hepatocellular and Biliary Expression of HLA Antigens in Primary Biliary Cirrhosis before and after Ursodeoxycholic Acid Therapy. Terasaki, Shuichi; Nakanuma, Yasuni; Ogino, Hidero; Unoura, Masashi; Kobayashi, Kenichi // American Journal of Gastroenterology;Sep1991, Vol. 86 Issue 9, p1194 

    Recently, there have been reports that ursodeoxycholic acid (UDCA) therapy has a beneficial effect on liver function in patients with primary biliary cirrhosis. However, information regarding the effects of UDCA therapy on hepatic histology remains insufficient. Aberrant expression of HLA...

  • SUCCESSFUL STEROID TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA AFTER ORTHOTOPIC LIVER TRANSPLANTATION FOR PRIMARY BILIARY CIRRHOSIS. Fickert, Peter; Trauner, Michael; Sill, Heinz; Hinterleitner, Thomas A.; Stuuber, Rudolf E. // American Journal of Gastroenterology;Oct1998, Vol. 93 Issue 10, p1985 

    Primary biliary cirrhosis (PBC) is an autoimmune disease of the liver frequently associated with extrahepatic autoimmune phentimena. Specific antibodies against platelet lycoproteins may play an important role in the pathogenesis of thrombocytopenia associated with PBC. This is the first report...

  • Impact of early biliary complications in liver transplantation in the presence or absence of a T-tube: a Chinese transplant centre experience. Tang Li; Zhi-Shui Chen; Fan-Jun Zeng; Chang-Sheng Ming; Wel-Jie Zhang; Dun-Gui Liu; Il-Ping Jiang; Dun-Feng Du; Zhong-Hua Klaus Chen // Postgraduate Medical Journal;Feb2007, Vol. 83 Issue 976, p120 

    Background: Biliary complications continue to be an important determinant of the recipient's survival rate after orthotopic liver transplantation (OLT). The objective of this study was to evaluate the incidence of early biliary complications in OLT in the presence or absence of a 1-tube....

  • Clinical features and management of primary biliary cirrhosis. Crosignani, Andrea; Battezzati, Pier Maria; Invernizzi, Pietro; Selmi, Carlo; Prina, Carlo; Podda, Mauro // World Journal of Gastroenterology;6/7/2008, Vol. 14 Issue 21, p3313 

    Primary biliary cirrhosis (PBC), which is characterised by progressive destruction of intrahepatic bile ducts, is not a rare disease since both prevalence and incidence are increasing during the last years mainly due to the improvement of case finding strategies. The prognosis of the disease has...

  • Is there a Role for Cyclophilin Inhibitors in the Management of Primary Biliary Cirrhosis? Wasilenko, Shawn T.; Montano-Loza, J.; Mason, Andrew L. // Viruses (1999-4915);Feb2013, Vol. 5 Issue 2, p423 

    Autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) are poorly understood autoimmune liver diseases. Immunosuppression is used to treat AIH and ursodeoxycholic acid is used to slow the progression of PBC. Nevertheless, a proportion of patients with both disorders progress to liver...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics